Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Ilyad: A Phase III Double Blind, Randomized Trial Evaluating Vitamin D (Cholecalciferol) in Patients with Low Tumor-Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab Therapy

Jonathan W. Friedberg, Michael T. Brady, Strawderman Myla, Brad S. Kahl, Izidore S. Lossos, Jonathon B. Cohen, Patrick M. Reagan, Carla Casulo, Barbara L. Averill, Brian K. Link, Paul M. Barr, John P. Leonard, John M. Ashton, Derick R Peterson, Loretta J. Nastoupil

Blood (2023) 142 (Supplement 1): 606.

https://doi.org/10.1182/blood-2023-178088

Published: 2023

Journal Articles

Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival in Patients with Low Tumor Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab

Jonathan W. Friedberg, MD, Michael T. Brady, PhD, Myla Strawderman, MS, Brad S. Kahl, MD, John P. Leonard, MD, Izidore S. Lossos, MD, Christopher R. Flowers, MD MS, Grerk Sutamtewagul, MD, Jonathon B. Cohen, MDMS, Derick R. Peterson, PhD, Loretta J. Nastoupil, MD MSc

Blood (2019) 134 (Supplement_1): 4008.

https://doi.org/10.1182/blood-2019-127320

Published: 2019

Journal Articles

Mesenchymal Stromal Cells Support Follicular Lymphoma-Associated Follicular Helper T-Cells, in Part, Through an IL-6 and IL-21-Dependent Mechanism.

Michael T. Brady, PhD, Shannon P. Hilchey, PhD, Steven H. Bernstein, MD

Blood (2012) 120 (21): 2707.

https://doi.org/10.1182/blood.V120.21.2707.2707

Published: 2012

Journal Articles

Signal Transducer and Activator of Transcription 3 Promotes Leukemogenesis

Sampa Ghoshal, Michael T Brady, PhD, Omar Ustwani, MD, Erin Tracy, Jason Den Haese, Paul K. Wallace, MS, PhD, Heinz Baumann, Meir Wetzler, MD

Blood (2011) 118 (21): 1395.

https://doi.org/10.1182/blood.V118.21.1395.1395

Published: 2011

Journal Articles

Follicular lymphoma tumor–infiltrating T-helper (T H ) cells have the same polyfunctional potential as normal nodal T H cells despite skewed differentiation

Shannon P. Hilchey, Alexander F. Rosenberg, Ollivier Hyrien, Shelley Secor-Socha, Matthew R. Cochran, Michael T. Brady, Jyh-Chiang E. Wang, Iñaki Sanz, W. Richard Burack, Sally A. Quataert, Steven H. Bernstein

Blood (2011) 118 (13): 3591–3602.

https://doi.org/10.1182/blood-2011-03-340646

Published: 2011

Includes: Supplemental data

Journal Articles

Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function

Michael T Brady, PhD, Austin Miller, PhD, Sheila Sait, PhD, Laurie A Ford, BS, CCRC, Minderman Hans, PhD, Eunice S. Wang, MD, Kelvin P Lee, MD, Heinz Baumann, Meir Wetzler, MD

Blood (2010) 116 (21): 3140.

https://doi.org/10.1182/blood.V116.21.3140.3140

Published: 2010

Journal Articles

Knock-Down of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function.

Michael T. Brady, MS, Sheila N.J. Sait, PhD, Hans Minderman, PhD, Kelvin P. Lee, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 1972.

https://doi.org/10.1182/blood.V114.22.1972.1972

Published: 2009

NARROW

Ilyad: A Phase III Double Blind, Randomized Trial Evaluating Vitamin D (Cholecalciferol) in Patients with Low Tumor-Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab Therapy

Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival in Patients with Low Tumor Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab

Mesenchymal Stromal Cells Support Follicular Lymphoma-Associated Follicular Helper T-Cells, in Part, Through an IL-6 and IL-21-Dependent Mechanism.

Signal Transducer and Activator of Transcription 3 Promotes Leukemogenesis

Follicular lymphoma tumor–infiltrating T-helper (T H ) cells have the same polyfunctional potential as normal nodal T H cells despite skewed differentiation

Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function

Knock-Down of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function.

Email alerts

ASH Publications

American Society of Hematology

Ilyad: A Phase III Double Blind, Randomized Trial Evaluating Vitamin D (Cholecalciferol) in Patients with Low Tumor-Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab Therapy

Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival in Patients with Low Tumor Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab

Mesenchymal Stromal Cells Support Follicular Lymphoma-Associated Follicular Helper T-Cells, in Part, Through an IL-6 and IL-21-Dependent Mechanism.

Signal Transducer and Activator of Transcription 3 Promotes Leukemogenesis

Follicular lymphoma tumor–infiltrating T-helper (T H ) cells have the same polyfunctional potential as normal nodal T H cells despite skewed differentiation

Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function

Knock-Down of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only